Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1915 1
1918 1
1938 1
1941 2
1946 3
1947 3
1948 3
1949 8
1950 8
1951 15
1952 17
1953 16
1954 19
1955 24
1956 14
1957 25
1958 30
1959 32
1960 32
1961 30
1962 42
1963 29
1964 110
1965 120
1966 192
1967 233
1968 269
1969 320
1970 295
1971 318
1972 286
1973 299
1974 309
1975 293
1976 321
1977 378
1978 349
1979 333
1980 388
1981 315
1982 262
1983 247
1984 431
1985 380
1986 424
1987 504
1988 544
1989 656
1990 668
1991 705
1992 820
1993 833
1994 1103
1995 1020
1996 1255
1997 1180
1998 1286
1999 1399
2000 1542
2001 1648
2002 1584
2003 1757
2004 2190
2005 2271
2006 2498
2007 2792
2008 3068
2009 3676
2010 4326
2011 5001
2012 5716
2013 6374
2014 7217
2015 8090
2016 8721
2017 9203
2018 9544
2019 10657
2020 11066
2021 10359
2022 5182
Text availability
Article attribute
Article type
Publication date

Search Results

129,647 results
Results by year
Filters applied: . Clear all
Page 1
Tumor xenograft animal models for esophageal squamous cell carcinoma.
Lee NP, Chan CM, Tung LN, Wang HK, Law S. Lee NP, et al. J Biomed Sci. 2018 Aug 29;25(1):66. doi: 10.1186/s12929-018-0468-7. J Biomed Sci. 2018. PMID: 30157855 Free PMC article. Review.
One factor contributing to this clinical dismal is the incomplete understanding of disease mechanism, for which this situation is further compounded by the presence of other limiting factors for disease diagnosis, patient prognosis and treatments. Tumor xenograft animal mo …
One factor contributing to this clinical dismal is the incomplete understanding of disease mechanism, for which this situation is further co …
Delayed xenograft rejection.
Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC. Bach FH, et al. Immunol Today. 1996 Aug;17(8):379-84. doi: 10.1016/0167-5699(96)10024-4. Immunol Today. 1996. PMID: 8783499 Review.
Despite considerable progress in understanding the mechanisms of discordant xenograft rejection, and overcoming hyperacute rejection through targeting of complement or antibody, vascularized xenografts are typically rejected within days. Here, Fritz Bach and colleag …
Despite considerable progress in understanding the mechanisms of discordant xenograft rejection, and overcoming hyperacute rejection …
Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines.
Miwa T, Kanda M, Umeda S, Tanaka H, Shimizu D, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y. Miwa T, et al. In Vivo. 2019 Nov-Dec;33(6):1785-1792. doi: 10.21873/invivo.11669. In Vivo. 2019. PMID: 31662503 Free PMC article.
BACKGROUND/AIM: Establishment of mouse xenograft models is necessary for oncological research and depends on the characteristics of the cell lines and the immune system of the host. ...We identified hepatic metastasis formation after direct injection of MKN45-Luc and MKN1- …
BACKGROUND/AIM: Establishment of mouse xenograft models is necessary for oncological research and depends on the characteristics of t …
Studying Xenograft Rejection of Bioprosthetic Heart Valves.
Manji RA, Manji JS. Manji RA, et al. Methods Mol Biol. 2020;2110:227-243. doi: 10.1007/978-1-0716-0255-3_15. Methods Mol Biol. 2020. PMID: 32002912
However, as younger patients likely have a more robust immune system than older adults, there is a new hypothesis that BHV xenografts may undergo xenograft rejection, and this may contribute to the early SVD seen in younger patients.At present, the technology to non …
However, as younger patients likely have a more robust immune system than older adults, there is a new hypothesis that BHV xenografts
Cellular Immune Responses in Islet Xenograft Rejection.
Hu M, Hawthorne WJ, Yi S, O'Connell PJ. Hu M, et al. Front Immunol. 2022 Jul 7;13:893985. doi: 10.3389/fimmu.2022.893985. eCollection 2022. Front Immunol. 2022. PMID: 35874735 Free PMC article. Review.
Although they are less important than CD4(+) T cells in islet xenograft rejection, macrophages are believed to be a major effector cell in this response. ...B cells are an important mediator of islet xenograft rejection via xenoantigen presentation, priming effector …
Although they are less important than CD4(+) T cells in islet xenograft rejection, macrophages are believed to be a major effector ce …
Xenotransplantation-the current status and prospects.
Cooper DKC, Gaston R, Eckhoff D, Ladowski J, Yamamoto T, Wang L, Iwase H, Hara H, Tector M, Tector AJ. Cooper DKC, et al. Br Med Bull. 2018 Mar 1;125(1):5-14. doi: 10.1093/bmb/ldx043. Br Med Bull. 2018. PMID: 29228112 Free PMC article. Review.
INTRODUCTION: There is a continuing worldwide shortage of organs from deceased human donors for transplantation into patients with end-stage organ failure. Genetically engineered pigs could resolve this problem, and could also provide tissues and cells for the treatment of …
INTRODUCTION: There is a continuing worldwide shortage of organs from deceased human donors for transplantation into patients with en …
Pig kidney xenotransplantation: Progress toward clinical trials.
Cooper DKC, Hara H, Iwase H, Yamamoto T, Wang ZY, Jagdale A, Bikhet MH, Nguyen HQ, Foote JB, Paris WD, Ayares D, Kumar V, Anderson DJ, Locke JE, Eckhoff DE. Cooper DKC, et al. Clin Transplant. 2021 Jan;35(1):e14139. doi: 10.1111/ctr.14139. Epub 2020 Nov 19. Clin Transplant. 2021. PMID: 33131148 Review.
Pig organ xenotransplantation offers a solution to the shortage of deceased human organs for transplantation. The pathobiological response to a pig xenograft is complex, involving antibody, complement, coagulation, inflammatory, and cellular responses. ...Non-immuno …
Pig organ xenotransplantation offers a solution to the shortage of deceased human organs for transplantation. The pathobiological res …
Murine xenograft bioreactors for human immunopeptidome discovery.
Heather JM, Myers PT, Shi F, Aziz-Zanjani MO, Mahoney KE, Perez M, Morin B, Brittsan C, Shabanowitz J, Hunt DF, Cobbold M. Heather JM, et al. Sci Rep. 2019 Dec 6;9(1):18558. doi: 10.1038/s41598-019-54700-2. Sci Rep. 2019. PMID: 31811195 Free PMC article.
To overcome this problem, we pose the hypothesis that human cells grown as xenografts in immunodeficient mice should produce equivalent immunopeptidomes as cultured cells. Comparing human cell lines grown either in vitro or as murine xenografts, we show that the imm …
To overcome this problem, we pose the hypothesis that human cells grown as xenografts in immunodeficient mice should produce equivale …
129,647 results
You have reached the last available page of results. Please see the User Guide for more information.